Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Dave O. who wrote (2761)	4/13/2010 11:21:56 AM
From: Jibacoa	Respond to of 3722

AGEN's volume is already above the 19,468,500 traded on Oct21,the day of the DG, but still below the 52,585,00 traded on June3 the 6th day of that up-move.<g> bigcharts.marketwatch.com It seems that with some good news it should be able to close the Oct DG.<g> Bernard

To: Dave O. who wrote (2761)	4/28/2010 10:14:06 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

MIPI seems to have found support at the $2.10 level.<g> bigcharts.marketwatch.com It was trading up almost 16% in pre-market and is still up 7.55% on low volume. It announced that it received a notification from the NAZ that is now in compliance for continued listing.<g. MIPI has almost closed its Apr13 UG and with some good news could get back to the $3 level.<g> bigcharts.marketwatch.com The spike on Apr13 was after it announced after the market closed on Apr12 that the results from a PII of Onalta had been published in the Journal of Clinical Oncology. The results from the PII on 90 patients showed that treatment with Onalta improved symptoms associated with metastatic carcinoid tumors. Median progression-free survival and overall survival were 16.3 and 26.9 months, respectively. Bernard